SCHEMBL33525287

SCHEMBL33525287

CCc1ccccc1NC=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
MAPT P10636 3/20 0.46
GAA P10253 3/20 0.46
TSHR P16473 2/20 0.44
POLB P06746 2/20 0.42
GRIN2D O15399 1/20 0.42
GRIN3B O60391 1/20 0.42
GRIN1 Q05586 1/20 0.42
GRIN2A Q12879 1/20 0.42
GRIN2B Q13224 1/20 0.42
GRIN2C Q14957 1/20 0.42
GRIN3A Q8TCU5 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2243716 1.00 ALDH1A1 (0.46) ALDH1A1MAPTGAATSHRPOLB
SCHEMBL28297001 0.86 ALDH1A1 (0.37) ALDH1A1MAPTGAATSHRPOLB
SCHEMBL7533909 0.86 ADRA2B (0.41) ALDH1A1MAPTGAATSHRPOLB
SCHEMBL21995029 0.84 TSHR (0.46) ALDH1A1MAPTGAATSHRNPSR1
SCHEMBL8763037 0.84 TSHR (0.46) ALDH1A1MAPTGAATSHRNPSR1
SCHEMBL14390806 0.83 CYP3A4 (0.44) ALDH1A1TSHRPOLBSIGMAR1
SCHEMBL4625754 0.83 MAPT (0.46) ALDH1A1MAPTGAATSHRPOLB
SCHEMBL11286222 0.83 TSHR (0.44) ALDH1A1MAPTGAATSHRNPSR1
SCHEMBL23396676 0.82 TSHR (0.41) ALDH1A1MAPTTSHRPOLBLMNA
Quinoline SCHEMBL28295243 0.81 ALDH1A1 (0.49) ALDH1A1MAPTPOLBHDAC3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4721985-A1 LIQUID EJECTING HEAD AND ONE-LIQUID TYPE GLUE Seiko Epson Corporation (JP) 2026-04-08 EP claimed
US-20260092207-A1 Liquid Ejecting Head And One-Liquid Type Glue SEIKO EPSON CORP (JP) 2026-04-02 US claimed
US-20260091588-A1 Liquid Ejecting Head And Two-Liquid Mixed Glue SEIKO EPSON CORP (JP) 2026-04-02 US claimed
EP-4721985-A1 LIQUID EJECTING HEAD AND ONE-LIQUID TYPE GLUE Seiko Epson Corporation (JP) 2026-04-08 EP disclosed
EP-4721986-A1 LIQUID EJECTING HEAD AND TWO-LIQUID MIXED GLUE Seiko Epson Corporation (JP) 2026-04-08 EP disclosed
US-20260092207-A1 Liquid Ejecting Head And One-Liquid Type Glue SEIKO EPSON CORP (JP) 2026-04-02 US disclosed
US-20260091588-A1 Liquid Ejecting Head And Two-Liquid Mixed Glue SEIKO EPSON CORP (JP) 2026-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260091588-A1 Liquid Ejecting Head And Two-Liquid Mixed Glue CARM1, MECP2, DOT1L ALDH1A1 1639/4885MAPT 1152/4885GAA 4860/4885
US-20260092207-A1 Liquid Ejecting Head And One-Liquid Type Glue DOT1L, SETDB1, NSD1 ALDH1A1 1023/4885MAPT 1045/4885GAA 3105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.